Clinical Trials Logo

Status Epilepticus clinical trials

View clinical trials related to Status Epilepticus.

Filter by:

NCT ID: NCT00362141 Recruiting - Status Epilepticus Clinical Trials

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

Start date: October 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether levetiracetam is safe and well tolerated by patients while suffering a status epilepticus. Levetiracetam is added to the standard treatment of patients with this disease.

NCT ID: NCT00343096 Terminated - Status Epilepticus Clinical Trials

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

Start date: June 2006
Phase: Phase 3
Study type: Interventional

This study aims to address the hypothesis that Lorazepam (an anticonvulsant) is as effective when given via the intranasal or buccal route as the intravenous route in terminating convulsions in children.

NCT ID: NCT00318578 Completed - Status Epilepticus Clinical Trials

Prognosis Factors Associated With Convulsive Status Epilepticus in Adults

Start date: March 2005
Phase: N/A
Study type: Observational

The aim of the study is to evaluate, prospectively, prognosis factors associated with convulsive status epilepticus (CSE) in adults hospitalized in intensive care units.

NCT ID: NCT00265616 Terminated - Status Epilepticus Clinical Trials

Treatment of Refractory Status Epilepticus

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether propofol or barbiturates should be preferred in the treatment of status epilepticus (continuous seizure activity) refractory to 2 standard antiepileptic agents.

NCT ID: NCT00116064 Completed - Status Epilepticus Clinical Trials

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate intranasal lorazepam in paediatric status epilepticus. This is a potentially, more effective, safer and cheaper treatment for a common paediatric medical emergency compared to our present first line therapy intramuscular paraldehyde.

NCT ID: NCT00114569 Completed - Status Epilepticus Clinical Trials

Lorazepam for the Treatment of Status Epilepticus in Children

Start date: March 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to gather the data to: 1) determine the best dose, and 2) evaluate its effectiveness and safety in stopping seizures. Part 1 is a pharmacokinetic study (study of how much drug is found in the body after it is given through a vein and how fast the body gets rid of the drug).

NCT ID: NCT00004297 Completed - Status Epilepticus Clinical Trials

Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus

Start date: November 1995
Phase: Phase 3
Study type: Interventional

OBJECTIVES: I. Compare the efficacy, onset of clinical anticonvulsant activity, and complications of diazepam and lorazepam given intravenously as prehospital therapy to patients in status epilepticus. II. Determine the effect of prehospital therapy on the incidence of status epilepticus at the subsequent emergency department admission. III. Establish whether prehospital therapy alters hospital management of these patients and ultimately affects patient outcome.